SEPTIN9 and cancer: Our hypothesis is that poor vascularisation, lower numbers of apoptotic or necrotic cells [47], [48] and additional factors such as high activity of DNase in plasma [49]–[51] are responsible for lower levels of DNA released into the blood stream in adenomas as compared to cancer and that this may be responsible for the different detection levels of SEPT9 in plasma.